In-Hyun Park, Ph.D. - Publications

2005 University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
Cell Biology

85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hu X, Wu Q, Zhang J, Kim J, Chen X, Hartman AA, Eastman AE, Park IH, Guo S. Reprogramming progressive cells display low CAG promoter activity. Stem Cells (Dayton, Ohio). PMID 33075202 DOI: 10.1002/stem.3295  0.323
2020 Wang K, Zhang H, He Y, Jiang Q, Tanaka Y, Park IH, Pober JS, Min W, Zhou HJ. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA120314586. PMID 32640906 DOI: 10.1161/Atvbaha.120.314586  0.341
2020 Xiang Y, Tanaka Y, Patterson B, Hwang SM, Hysolli E, Cakir B, Kim KY, Wang W, Kang YJ, Clement EM, Zhong M, Lee SH, Cho YS, Patra P, Sullivan GJ, ... ... Park IH, et al. Dysregulation of BRD4 Function Underlies the Functional Abnormalities of MeCP2 Mutant Neurons. Molecular Cell. PMID 32526163 DOI: 10.1016/J.Molcel.2020.05.016  0.347
2020 Yoon Y, Kim HS, Jeon I, Noh JE, Park HJ, Lee S, Park IH, Stevanato L, Hicks C, Corteling R, Barker RA, Sinden JD, Song J. Implantation of the clinical-grade human neural stem cell line, CTX0E03, rescues the behavioral and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease. Stem Cells (Dayton, Ohio). PMID 32374064 DOI: 10.1002/Stem.3191  0.337
2019 Cakir B, Xiang Y, Tanaka Y, Kural MH, Parent M, Kang YJ, Chapeton K, Patterson B, Yuan Y, He CS, Raredon MSB, Dengelegi J, Kim KY, Sun P, Zhong M, ... ... Park IH, et al. Engineering of human brain organoids with a functional vascular-like system. Nature Methods. PMID 31591580 DOI: 10.1038/S41592-019-0586-5  0.33
2019 Belair C, Sim S, Kim KY, Tanaka Y, Park IH, Wolin SL. The RNA exosome nuclease complex regulates human embryonic stem cell differentiation. The Journal of Cell Biology. PMID 31308215 DOI: 10.1083/Jcb.201811148  0.399
2019 Xiang Y, Tanaka Y, Cakir B, Patterson B, Kim KY, Sun P, Kang YJ, Zhong M, Liu X, Patra P, Lee SH, Weissman SM, Park IH. hESC-Derived Thalamic Organoids Form Reciprocal Projections When Fused with Cortical Organoids. Cell Stem Cell. PMID 30799279 DOI: 10.1016/J.Stem.2018.12.015  0.341
2018 Patterson B, Tanaka Y, Park IH. Correction to: New Advances in Human X Chromosome Status from a Developmental and Stem Cell Biology. Tissue Engineering and Regenerative Medicine. 15: 125. PMID 30603540 DOI: 10.1007/S13770-017-0111-9  0.349
2017 Patterson B, Tanaka Y, Park IH. New Advances in Human X chromosome status from a Developmental and Stem Cell Biology. Tissue Engineering and Regenerative Medicine. 14: 643-652. PMID 29276809 DOI: 10.1007/S13770-017-0096-4  0.393
2017 Xiang Y, Tanaka Y, Patterson B, Kang YJ, Govindaiah G, Roselaar N, Cakir B, Kim KY, Lombroso AP, Hwang SM, Zhong M, Stanley EG, Elefanty AG, Naegele JR, Lee SH, ... ... Park IH, et al. Fusion of Regionally Specified hPSC-Derived Organoids Models Human Brain Development and Interneuron Migration. Cell Stem Cell. PMID 28757360 DOI: 10.1016/J.Stem.2017.07.007  0.346
2017 Han L, Wu HJ, Zhu H, Kim KY, Marjani SL, Riester M, Euskirchen G, Zi X, Yang J, Han J, Snyder M, Park IH, Irizarry R, Weissman SM, Michor F, et al. Bisulfite-independent analysis of CpG island methylation enables genome-scale stratification of single cells. Nucleic Acids Research. PMID 28126923 DOI: 10.1093/Nar/Gkx026  0.35
2016 Yang J, Tanaka Y, Seay M, Li Z, Jin J, Garmire LX, Zhu X, Taylor A, Li W, Euskirchen G, Halene S, Kluger Y, Snyder MP, Park IH, Pan X, et al. Single cell transcriptomics reveals unanticipated features of early hematopoietic precursors. Nucleic Acids Research. PMID 28003475 DOI: 10.1093/Nar/Gkw1214  0.425
2016 Liu R, Kim KY, Jung YW, Park IH. Dnmt1 regulates the myogenic lineage specification of muscle stem cells. Scientific Reports. 6: 35355. PMID 27752090 DOI: 10.1038/Srep35355  0.368
2016 Park CY, Sung JJ, Choi SH, Lee DR, Park IH, Kim DW. Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9. Nature Protocols. 11: 2154-2169. PMID 27711053 DOI: 10.1038/Nprot.2016.129  0.305
2015 Xiang Y, Kim KY, Gelernter J, Park IH, Zhang H. Ethanol Upregulates NMDA Receptor Subunit Gene Expression in Human Embryonic Stem Cell-Derived Cortical Neurons. Plos One. 10: e0134907. PMID 26266540 DOI: 10.1371/Journal.Pone.0134907  0.308
2015 Tanaka Y, Hysolli E, Su J, Xiang Y, Kim KY, Zhong M, Li Y, Heydari K, Euskirchen G, Snyder MP, Pan X, Weissman SM, Park IH. Transcriptome Signature and Regulation in Human Somatic Cell Reprogramming. Stem Cell Reports. 4: 1125-39. PMID 26004630 DOI: 10.1016/J.Stemcr.2015.04.009  0.442
2015 Kwon YW, Paek JS, Cho HJ, Lee CS, Lee HJ, Park IH, Roh TY, Kang CM, Yang HM, Park YB, Kim HS. Role of Zscan4 in secondary murine iPSC derivation mediated by protein extracts of ESC or iPSC. Biomaterials. 59: 102-15. PMID 25956855 DOI: 10.1016/j.biomaterials.2015.03.031  0.317
2015 Astle J, Xiang Y, Rongvaux A, Weibel C, Elizabeth H, Halene S, Park I, Flavell R. Developing a Model of Human Pluripotent to Hematopoietic Stem Cell Development in Mistrg Mice Blood. 126: 4755-4755. DOI: 10.1182/Blood.V126.23.4755.4755  0.401
2014 Kim KY, Hysolli E, Tanaka Y, Wang B, Jung YW, Pan X, Weissman SM, Park IH. X Chromosome of female cells shows dynamic changes in status during human somatic cell reprogramming. Stem Cell Reports. 2: 896-909. PMID 24936474 DOI: 10.1016/J.Stemcr.2014.04.003  0.319
2014 Jeon I, Choi C, Lee N, Im W, Kim M, Oh SH, Park IH, Kim HS, Song J. In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease. International Journal of Stem Cells. 7: 43-7. PMID 24921027 DOI: 10.15283/Ijsc.2014.7.1.43  0.351
2014 Tanaka Y, Kim KY, Zhong M, Pan X, Weissman SM, Park IH. Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2). Human Molecular Genetics. 23: 1045-55. PMID 24129406 DOI: 10.1093/Hmg/Ddt500  0.429
2013 Hysolli E, Park IH. Trivalent chromatin marks the way in. Cell Stem Cell. 13: 510-2. PMID 24209756 DOI: 10.1016/J.Stem.2013.10.007  0.347
2013 Larimore J, Ryder PV, Kim KY, Ambrose LA, Chapleau C, Calfa G, Gross C, Bassell GJ, Pozzo-Miller L, Smith Y, Talbot K, Park IH, Faundez V. MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons. Plos One. 8: e65069. PMID 23750231 DOI: 10.1371/Journal.Pone.0065069  0.338
2013 Dajani R, Koo SE, Sullivan GJ, Park IH. Investigation of Rett syndrome using pluripotent stem cells. Journal of Cellular Biochemistry. 114: 2446-53. PMID 23744605 DOI: 10.1002/Jcb.24597  0.413
2013 Lee JB, Werbowetski-Ogilvie TE, Lee JH, McIntyre BA, Schnerch A, Hong SH, Park IH, Daley GQ, Bernstein ID, Bhatia M. Notch-HES1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells. Blood. 122: 1162-73. PMID 23733337 DOI: 10.1182/Blood-2012-12-471649  0.363
2013 Tulpule A, Kelley JM, Lensch MW, McPherson J, Park IH, Hartung O, Nakamura T, Schlaeger TM, Shimamura A, Daley GQ. Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction. Cell Stem Cell. 12: 727-36. PMID 23602541 DOI: 10.1016/J.Stem.2013.04.002  0.315
2013 Lee ST, Gong SP, Yum KE, Lee EJ, Lee CH, Choi JH, Kim DY, Han H, Kim KS, Hysolli E, Ahn JY, Park IH, Han JY, Jeong JW, Lim JM. Transformation of somatic cells into stem cell-like cells under a stromal niche. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2644-56. PMID 23580613 DOI: 10.1096/fj.12-223065  0.336
2013 Siller R, Greenhough S, Park IH, Sullivan GJ. Modelling human disease with pluripotent stem cells. Current Gene Therapy. 13: 99-110. PMID 23444871 DOI: 10.2174/1566523211313020004  0.366
2013 Pan X, Durrett RE, Zhu H, Tanaka Y, Li Y, Zi X, Marjani SL, Euskirchen G, Ma C, Lamotte RH, Park IH, Snyder MP, Mason CE, Weissman SM. Two methods for full-length RNA sequencing for low quantities of cells and single cells. Proceedings of the National Academy of Sciences of the United States of America. 110: 594-9. PMID 23267071 DOI: 10.1073/Pnas.1217322109  0.339
2013 Chang DJ, Lee N, Park IH, Choi C, Jeon I, Kwon J, Oh SH, Shin DA, Do JT, Lee DR, Lee H, Moon H, Hong KS, Daley GQ, Song J. Therapeutic potential of human induced pluripotent stem cells in experimental stroke. Cell Transplantation. 22: 1427-40. PMID 23044029 DOI: 10.3727/096368912X657314  0.32
2012 Tanaka Y, Chung L, Park IH. Impact of retrotransposons in pluripotent stem cells. Molecules and Cells. 34: 509-16. PMID 23135636 DOI: 10.1007/S10059-012-0242-8  0.376
2012 Maclean GA, Menne TF, Guo G, Sanchez DJ, Park IH, Daley GQ, Orkin SH. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 17567-72. PMID 23045682 DOI: 10.1182/Blood.V118.21.921.921  0.406
2012 Ge X, Ren Y, Bartulos O, Lee MY, Yue Z, Kim KY, Li W, Amos PJ, Bozkulak EC, Iyer A, Zheng W, Zhao H, Martin KA, Kotton DN, Tellides G, ... Park IH, et al. Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. Circulation. 126: 1695-704. PMID 22914687 DOI: 10.1161/Circulationaha.112.116996  0.439
2012 Kim KY, Jung YW, Sullivan GJ, Chung L, Park IH. Cellular reprogramming: a novel tool for investigating autism spectrum disorders. Trends in Molecular Medicine. 18: 463-71. PMID 22771169 DOI: 10.1016/J.Molmed.2012.06.002  0.328
2012 Chae JI, Kim DW, Lee N, Jeon YJ, Jeon I, Kwon J, Kim J, Soh Y, Lee DS, Seo KS, Choi NJ, Park BC, Kang SH, Ryu J, Oh SH, ... ... Park IH, et al. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. The Biochemical Journal. 446: 359-71. PMID 22694310 DOI: 10.1042/Bj20111495  0.316
2012 Loh YH, Yang JC, De Los Angeles A, Guo C, Cherry A, Rossi DJ, Park IH, Daley GQ. Excision of a viral reprogramming cassette by delivery of synthetic Cre mRNA. Current Protocols in Stem Cell Biology. Unit4A.5. PMID 22605648 DOI: 10.1002/9780470151808.Sc04A05S21  0.412
2012 Kim KY, Hysolli E, Park IH. Reprogramming human somatic cells into induced pluripotent stem cells (iPSCs) using retroviral vector with GFP. Journal of Visualized Experiments : Jove. PMID 22491226 DOI: 10.3791/3804  0.429
2012 Müller LU, Milsom MD, Harris CE, Vyas R, Brumme KM, Parmar K, Moreau LA, Schambach A, Park IH, London WB, Strait K, Schlaeger T, Devine AL, Grassman E, D'Andrea A, et al. Overcoming reprogramming resistance of Fanconi anemia cells. Blood. 119: 5449-57. PMID 22371882 DOI: 10.1182/Blood-2012-02-408674  0.463
2012 Zhou XL, Sullivan GJ, Sun P, Park IH. Humanized murine model for HBV and HCV using human induced pluripotent stem cells. Archives of Pharmacal Research. 35: 261-9. PMID 22370780 DOI: 10.1007/S12272-012-0206-8  0.333
2012 Jung YW, Hysolli E, Kim KY, Tanaka Y, Park IH. Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies. Current Opinion in Neurology. 25: 125-30. PMID 22357218 DOI: 10.1097/Wco.0B013E3283518226  0.363
2012 Hysolli E, Jung YW, Tanaka Y, Kim KY, Park IH. The lesser known story of X chromosome reactivation: a closer look into the reprogramming of the inactive X chromosome. Cell Cycle (Georgetown, Tex.). 11: 229-35. PMID 22234239 DOI: 10.4161/Cc.11.2.18998  0.353
2012 Konantz M, Grauer M, Grzywna S, Park I, Daley GQ, Kanz L, Lengerke C. A Dual Role of Evi-1 During Developmental Hematopoiesis Blood. 120: 765-765. DOI: 10.1182/Blood.V120.21.765.765  0.45
2011 Ballabeni A, Park IH, Zhao R, Wang W, Lerou PH, Daley GQ, Kirschner MW. Cell cycle adaptations of embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 19252-7. PMID 22084091 DOI: 10.1073/Pnas.1116794108  0.396
2011 Kim KY, Hysolli E, Park IH. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proceedings of the National Academy of Sciences of the United States of America. 108: 14169-74. PMID 21807996 DOI: 10.1073/Pnas.1018979108  0.386
2011 Jang J, Kang HC, Kim HS, Kim JY, Huh YJ, Kim DS, Yoo JE, Lee JA, Lim B, Lee J, Yoon TM, Park IH, Hwang DY, Daley GQ, Kim DW. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Annals of Neurology. 70: 402-9. PMID 21721033 DOI: 10.1002/Ana.22486  0.359
2011 Tucker BA, Park IH, Qi SD, Klassen HJ, Jiang C, Yao J, Redenti S, Daley GQ, Young MJ. Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. Plos One. 6: e18992. PMID 21559507 DOI: 10.1371/Journal.Pone.0018992  0.33
2011 Nostro MC, Sarangi F, Ogawa S, Holtzinger A, Corneo B, Li X, Micallef SJ, Park IH, Basford C, Wheeler MB, Daley GQ, Elefanty AG, Stanley EG, Keller G. Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development (Cambridge, England). 138: 861-71. PMID 21270052 DOI: 10.1242/dev.055236  0.448
2011 Pessach IM, Ordovas-Montanes J, Zhang SY, Casanova JL, Giliani S, Gennery AR, Al-Herz W, Manos PD, Schlaeger TM, Park IH, Rucci F, Agarwal S, Mostoslavsky G, Daley GQ, Notarangelo LD. Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies. The Journal of Allergy and Clinical Immunology. 127: 1400-7.e4. PMID 21185069 DOI: 10.1016/J.Jaci.2010.11.008  0.441
2011 Jin J, Kwon YW, Paek JS, Cho HJ, Yu J, Lee JY, Chu IS, Park IH, Park YB, Kim HS, Kim Y. Analysis of differential proteomes of induced pluripotent stem cells by protein-based reprogramming of fibroblasts. Journal of Proteome Research. 10: 977-89. PMID 21175196 DOI: 10.1021/pr100624f  0.339
2011 Nostro MC, Sarangi F, Ogawa S, Holtzinger A, Corneo B, Li X, Micallef SJ, Park I, Basford C, Wheeler MB, Daley GQ, Elefanty AG, Stanley EG, Keller G. Stage-specific signaling through TGF  family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells Journal of Cell Science. 124: e1-e1. DOI: 10.1242/JCS.087957  0.301
2011 Mueller L, Milsom MD, Harris C, Vyas R, Brumme K, Parmar K, Schambach A, Grassman E, Park I, Wendy L, Strait K, Schlaeger T, Devine AL, D'Andrea AD, Daley GQ, et al. Gene-Correction Rescues Reprogramming of Fanconi Anemia Fibroblasts and Enables Hematopoietic Differentiation of FA Induced Pluripotent Stem Cells in Vitro and In Vivo Blood. 118: 672-672. DOI: 10.1182/Blood.V118.21.672.672  0.431
2011 Konantz M, Grauer M, Grzywna S, Brugman M, Kanz L, Park I, Daley GQ, Baum C, Lengerke C. Evi-1 Regulates Myelopoiesis and Hematopoietic Stem Cell Development in Zebrafish and Human Pluripotent Stem Cells Blood. 118: 1281-1281. DOI: 10.1182/Blood.V118.21.1281.1281  0.468
2010 Neveu P, Kye MJ, Qi S, Buchholz DE, Clegg DO, Sahin M, Park IH, Kim KS, Daley GQ, Kornblum HI, Shraiman BI, Kosik KS. MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell. 7: 671-81. PMID 21112562 DOI: 10.1016/J.Stem.2010.11.012  0.37
2010 Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, Manos PD, Datta S, Lander ES, Schlaeger TM, Daley GQ, et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nature Genetics. 42: 1113-7. PMID 21057500 DOI: 10.1038/Ng.710  0.34
2010 Kim DS, Lee JS, Leem JW, Huh YJ, Kim JY, Kim HS, Park IH, Daley GQ, Hwang DY, Kim DW. Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Reviews. 6: 270-81. PMID 20376579 DOI: 10.1007/S12015-010-9138-1  0.459
2010 Agarwal S, Loh YH, McLoughlin EM, Huang J, Park IH, Miller JD, Huo H, Okuka M, Dos Reis RM, Loewer S, Ng HH, Keefe DL, Goldman FD, Klingelhutz AJ, Liu L, et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature. 464: 292-6. PMID 20164838 DOI: 10.1038/Nature08792  0.39
2010 Park IH. DYS-HAC-iPS cells: The combination of gene and cell therapy to treat duchenne muscular dystrophy Molecular Therapy. 18: 238-240. PMID 20125163 DOI: 10.1038/Mt.2009.303  0.343
2010 Grigoriadis AE, Kennedy M, Bozec A, Brunton F, Stenbeck G, Park IH, Wagner EF, Keller GM. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood. 115: 2769-76. PMID 20065292 DOI: 10.1182/Blood-2009-07-234690  0.41
2010 Grauer M, Konantz M, Niebuhr NI, Kanz L, Park I, Daley GQ, Lengerke C. Hematopoietic development from human induced pluripotent stem cells F1000research. 1. DOI: 10.7490/F1000Research.127.1  0.409
2009 Lee JH, Park IH, Gao Y, Li JB, Li Z, Daley GQ, Zhang K, Church GM. A robust approach to identifying tissue-specific gene expression regulatory variants using personalized human induced pluripotent stem cells. Plos Genetics. 5: e1000718. PMID 19911041 DOI: 10.1371/Journal.Pgen.1000718  0.402
2009 Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, Hartung O, Rho J, Ince TA, Daley GQ, Schlaeger TM. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nature Biotechnology. 27: 1033-7. PMID 19826408 DOI: 10.1038/Nbt.1580  0.334
2009 Lengerke C, Grauer M, Niebuhr NI, Riedt T, Kanz L, Park IH, Daley GQ. Hematopoietic development from human induced pluripotent stem cells. Annals of the New York Academy of Sciences. 1176: 219-27. PMID 19796250 DOI: 10.1111/J.1749-6632.2009.04606.X  0.449
2009 Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, Gepstein L. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation. 120: 1513-23. PMID 19786631 DOI: 10.1161/Circulationaha.109.868885  0.414
2009 West JA, Viswanathan SR, Yabuuchi A, Cunniff K, Takeuchi A, Park IH, Sero JE, Zhu H, Perez-Atayde A, Frazier AL, Surani MA, Daley GQ. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature. 460: 909-13. PMID 19578360 DOI: 10.1038/Nature08210  0.465
2009 Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, Antosiewicz-Bourget J, Egli D, Maherali N, Park IH, Yu J, Daley GQ, Eggan K, Hochedlinger K, Thomson J, Wang W, et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nature Biotechnology. 27: 353-60. PMID 19330000 DOI: 10.1038/Nbt.1530  0.34
2009 Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, Park IH, Xie B, Daley GQ, Church GM. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nature Biotechnology. 27: 361-8. PMID 19329998 DOI: 10.1038/Nbt.1533  0.318
2009 Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ. Generation of induced pluripotent stem cells from human blood. Blood. 113: 5476-9. PMID 19299331 DOI: 10.1182/Blood-2009-02-204800  0.442
2009 Park IH, Daley GQ. Human iPS cell derivation/reprogramming. Current Protocols in Stem Cell Biology. Unit 4A.1. PMID 19170021 DOI: 10.1002/9780470151808.Sc04A01S8  0.444
2009 Agarwal S, Loh Y, McLoughlin EM, Huang J, Park I, Miller JD, Huo H, Okuka M, Reis RMd, Loewer S, Keefe D, Goldman FD, Klingelhutz A, Liu L, Daley GQ. Telomere Elongation in Dyskeratosis Congenita Induced Pluripotent Stem Cells. Blood. 114: 497-497. DOI: 10.1182/Blood.V114.22.497.497  0.4
2009 Ni Z, Knorr DA, Clouser CL, Southern P, Mansky LM, Park I, Kaufman DS. Natural Killer Cells Derived From Human Pluripotent Stem Cells Provide a Novel Method to Treat HIV-1 Infection. Blood. 114: 280-280. DOI: 10.1182/Blood.V114.22.280.280  0.34
2009 Grauer M, Konantz M, Niebuhr NI, Kanz L, Park I, Daley GQ, Lengerke C. Hematopoietic Development From Human Induced Pluripotent Stem Cells. Blood. 114: 2530-2530. DOI: 10.1182/Blood.V114.22.2530.2530  0.46
2009 Konantz M, Brugman MH, Park I, Daley GQ, Nuesslein-Volhard C, Baum C, Lengerke C. The Zebrafish Homologue of the Murine Ecotropic Viral Integration Site-1 (. Evi-1) gene Regulates Zebrafish Embryonic Blood Development. Blood. 114: 1461-1461. DOI: 10.1182/Blood.V114.22.1461.1461  0.431
2009 Ball MP, Billy Li J, Gao Y, Lee J, LeProust EM, Park I, Xie B, Daley GQ, Church GM. Erratum: Corrigendum: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells Nature Biotechnology. 27: 485-485. DOI: 10.1038/Nbt0509-485B  0.312
2008 Müller FJ, Laurent LC, Kostka D, Ulitsky I, Williams R, Lu C, Park IH, Rao MS, Shamir R, Schwartz PH, Schmidt NO, Loring JF. Regulatory networks define phenotypic classes of human stem cell lines. Nature. 455: 401-5. PMID 18724358 DOI: 10.1038/Nature07213  0.433
2008 Park IH, Lerou PH, Zhao R, Huo H, Daley GQ. Generation of human-induced pluripotent stem cells. Nature Protocols. 3: 1180-6. PMID 18600223 DOI: 10.1038/Nprot.2008.92  0.44
2008 Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 451: 141-6. PMID 18157115 DOI: 10.1038/Nature06534  0.343
2008 Tolar J, Park I, Xia L, Osborn M, McElmurry RT, Orchard PJ, Daley GQ, Blazar BR. Patient-Specific Induced Pluripotent Stem Cells in Hurler Syndrome Blood. 112: 386-386. DOI: 10.1182/Blood.V112.11.386.386  0.45
2007 Park IH, Daley GQ. Debugging cellular reprogramming. Nature Cell Biology. 9: 871-3. PMID 17671453 DOI: 10.1038/Ncb0807-871  0.44
2006 West JA, Park IH, Daley GQ, Geijsen N. In vitro generation of germ cells from murine embryonic stem cells. Nature Protocols. 1: 2026-36. PMID 17487192 DOI: 10.1038/Nprot.2006.303  0.426
2006 Bachmann RA, Kim JH, Wu AL, Park IH, Chen J. A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1. The Journal of Biological Chemistry. 281: 7357-63. PMID 16407298 DOI: 10.1074/Jbc.M512218200  0.69
2005 Park IH, Chen J. Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation. The Journal of Biological Chemistry. 280: 32009-17. PMID 16043480 DOI: 10.1074/jbc.M506120200  0.371
2005 Park IH, Erbay E, Nuzzi P, Chen J. Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1. Experimental Cell Research. 309: 211-9. PMID 15963500 DOI: 10.1016/J.Yexcr.2005.05.017  0.71
2003 Erbay E, Park IH, Nuzzi PD, Schoenherr CJ, Chen J. IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. The Journal of Cell Biology. 163: 931-6. PMID 14662739 DOI: 10.1083/Jcb.200307158  0.677
2003 Fang Y, Park IH, Wu AL, Du G, Huang P, Frohman MA, Walker SJ, Brown HA, Chen J. PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1. Current Biology : Cb. 13: 2037-44. PMID 14653992 DOI: 10.1016/J.Cub.2003.11.021  0.344
2002 Park IH, Bachmann R, Shirazi H, Chen J. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin. The Journal of Biological Chemistry. 277: 31423-9. PMID 12087098 DOI: 10.1074/Jbc.M204080200  0.692
Show low-probability matches.